Pharma Mar

Pharma Mar S.A.
Stock Exchange Other OTC
EPS
$0.13
Market Cap
$473.44 M
Shares Outstanding
222.2 M
Public Float
-
Pharma Mar S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
222.2 M
Public Float
-

Profile

Address
Avenida de los Reyes, 1
Colmenar Viejo Madrid 28770
Spain
Employees -
Website http://www.pharmamar.es
Updated 07/08/2019
Pharma Mar SA is a biopharmaceutical holding company, which engages in discovery and development of innovative marine-derived anticancer drugs. It operates through the following segments: Oncology, Diagnostics, RNAi, and Consumer Chemicals. The Oncology segment encompasses the Group undertakings whose object is to research, develop and market anti-tumour drugs.

Financials

View All
Created with Highcharts 5.0.14Pharma Mar S.A.Net Income. Fiscal year is January-December. All values EUR Thousands.11 84111 84113 17113 1716 6566 65624 08224 08226 74526 74516 18716 18720132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14Pharma Mar S.A.Sales/Revenue. Fiscal year is January-December. All values EUR Thousands.141 824141 824149 652149 652193 817193 817180 948180 948179 363179 363162 587162 587201320142015201620172018050k100k150k200k250k

José Maria Fernández de Sousa-Faro
Executive Chairman, President & CEO
José Francisco Leyte Verdejo
Director